PerQdisc will be studied in degenerative disc disease patients, according to a Nov. 15 company news release. The device replaces a single nucleus pulposus between spinal discs and is an alternative to spinal fusion and disc replacement.
The trial is enrolling 72 patients across seven research centers in South America.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
